AZD0914: Clinical Trials

3 trials of AZD0914, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow AZD0914: new trials by email Literature Review of AZD0914 trials Research Report on AZD0914

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects
AZD0914, Moxifloxacin, Placebo - Electrocardiogram Repolarisation Abnormality, Gonococcal Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)722018-09-252020-03-27
A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers
AZD0914 - Gonorrhoea
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)82018-02-022019-03-18
AZD0914 Phase 1 ADME Study in Healthy Volunteers
AZD0914 - Healthy
Phase 1CompletedEntasis Therapeutics62015-01-012015-06-03

Conditions studied

Gonorrhea (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Entasis Therapeutics (1)

Countries

United States (3)

Top investigators

Irene Mirkin, MD (1)

Results publications

PMID 30373802, PMID 34606332